Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6725189rdf:typepubmed:Citationlld:pubmed
pubmed-article:6725189lifeskim:mentionsumls-concept:C0302908lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C0025659lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C0680730lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C0039225lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C0681804lld:lifeskim
pubmed-article:6725189lifeskim:mentionsumls-concept:C1148554lld:lifeskim
pubmed-article:6725189pubmed:issue2lld:pubmed
pubmed-article:6725189pubmed:dateCreated1984-7-23lld:pubmed
pubmed-article:6725189pubmed:abstractTextA reverse phase liquid chromatographic method was developed for determining methocarbamol in injection and tablet dosage forms. The injections require dilution only; the tablets require a filtration step before introduction into the chromatograph. Response for methocarbamol was linear over the range 0-18 micrograms, using an ultraviolet detector at 274 nm. Recoveries by the author ranged from 96.1 to 101.9% for authentic injection formulations and 98.0 to 101.0% for authentic tablet formulations. A collaborative study of the method by 6 laboratories resulted in standard deviations of 1.70 and 2.22 for injection and tablet dosage forms, respectively. The method has been adopted official first action.lld:pubmed
pubmed-article:6725189pubmed:languageenglld:pubmed
pubmed-article:6725189pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6725189pubmed:citationSubsetIMlld:pubmed
pubmed-article:6725189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6725189pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6725189pubmed:statusMEDLINElld:pubmed
pubmed-article:6725189pubmed:issn0004-5756lld:pubmed
pubmed-article:6725189pubmed:authorpubmed-author:EverettR LRLlld:pubmed
pubmed-article:6725189pubmed:issnTypePrintlld:pubmed
pubmed-article:6725189pubmed:volume67lld:pubmed
pubmed-article:6725189pubmed:ownerNLMlld:pubmed
pubmed-article:6725189pubmed:authorsCompleteYlld:pubmed
pubmed-article:6725189pubmed:pagination225-7lld:pubmed
pubmed-article:6725189pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:6725189pubmed:meshHeadingpubmed-meshheading:6725189-...lld:pubmed
pubmed-article:6725189pubmed:meshHeadingpubmed-meshheading:6725189-...lld:pubmed
pubmed-article:6725189pubmed:meshHeadingpubmed-meshheading:6725189-...lld:pubmed
pubmed-article:6725189pubmed:meshHeadingpubmed-meshheading:6725189-...lld:pubmed
pubmed-article:6725189pubmed:meshHeadingpubmed-meshheading:6725189-...lld:pubmed
pubmed-article:6725189pubmed:articleTitleLiquid chromatographic determination of methocarbamol in injection and tablet dosage forms: collaborative study.lld:pubmed
pubmed-article:6725189pubmed:publicationTypeJournal Articlelld:pubmed